Entering text into the input field will update the search result below

Arrowhead Pharmaceuticals EPS misses by $0.16, misses on revenue

  • Arrowhead Pharmaceuticals (NASDAQ:ARWR): Q2 GAAP EPS of -$0.26 misses by $0.16.
  • Revenue of $32.81M (+39.6% Y/Y) misses by $6.61M.
  • Press Release

Recommended For You

About ARWR Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
ARWR--
Arrowhead Pharmaceuticals, Inc.